MedTrace Logo

PRP vs PRP Plus IGF for Patellar Tendinosis

NCT04350827 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2023-10-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare two different platelet-rich plasma (PRP) injections for patellar tendinosis.

Aim: To perform a randomized, double blinded study comparing the clinical effect of PRP versus PRP + concentrated insulin-like growth factor (IGF) in patients with patellar tendinosis.

Conditions

  • Tendinopathy
  • Patellar Ligament
  • Platelet-Rich Plasma

Interventions

DEVICE

Platelet Rich Plasma

Platelet rich plasma injection into patellar tendon

DEVICE

Platelet Rich Plasma plus IGF

Platelet rich plasma plus IGF injection into patellar tendon

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • Michael Baria, MD · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-25
Primary Completion
2021-10-16
Completion
2021-10-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04350827 on ClinicalTrials.gov